1. Home
  2. MTSR vs NOMD Comparison

MTSR vs NOMD Comparison

Compare MTSR & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSR
  • NOMD
  • Stock Information
  • Founded
  • MTSR 2022
  • NOMD 2014
  • Country
  • MTSR United States
  • NOMD United Kingdom
  • Employees
  • MTSR N/A
  • NOMD N/A
  • Industry
  • MTSR
  • NOMD Packaged Foods
  • Sector
  • MTSR
  • NOMD Consumer Staples
  • Exchange
  • MTSR NYSE
  • NOMD Nasdaq
  • Market Cap
  • MTSR 3.0B
  • NOMD 2.6B
  • IPO Year
  • MTSR 2025
  • NOMD N/A
  • Fundamental
  • Price
  • MTSR $27.09
  • NOMD $17.40
  • Analyst Decision
  • MTSR Strong Buy
  • NOMD Strong Buy
  • Analyst Count
  • MTSR 6
  • NOMD 3
  • Target Price
  • MTSR $55.25
  • NOMD $24.00
  • AVG Volume (30 Days)
  • MTSR 1.0M
  • NOMD 858.1K
  • Earning Date
  • MTSR 08-26-2025
  • NOMD 08-06-2025
  • Dividend Yield
  • MTSR N/A
  • NOMD 4.00%
  • EPS Growth
  • MTSR N/A
  • NOMD 27.52
  • EPS
  • MTSR N/A
  • NOMD 1.52
  • Revenue
  • MTSR N/A
  • NOMD $3,324,902,723.00
  • Revenue This Year
  • MTSR N/A
  • NOMD $2.81
  • Revenue Next Year
  • MTSR N/A
  • NOMD $2.23
  • P/E Ratio
  • MTSR N/A
  • NOMD $11.17
  • Revenue Growth
  • MTSR N/A
  • NOMD 0.76
  • 52 Week Low
  • MTSR $12.30
  • NOMD $15.43
  • 52 Week High
  • MTSR $37.99
  • NOMD $20.81
  • Technical
  • Relative Strength Index (RSI)
  • MTSR N/A
  • NOMD 49.54
  • Support Level
  • MTSR N/A
  • NOMD $16.86
  • Resistance Level
  • MTSR N/A
  • NOMD $17.21
  • Average True Range (ATR)
  • MTSR 0.00
  • NOMD 0.32
  • MACD
  • MTSR 0.00
  • NOMD 0.07
  • Stochastic Oscillator
  • MTSR 0.00
  • NOMD 70.51

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

Share on Social Networks: